Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing guidelines in musculoskeletal disorders.

M A Lopez-Olivo1, M E Suarez-Almazor

  • 1Section of Rheumatology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Clinical and Experimental Rheumatology
|November 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of multimedia and printed patient education tools for patients with osteoporosis: a 6-month randomized controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients.

Osteoarthritis and cartilage·2018
Same author

Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies.

British journal of anaesthesia·2018
Same author

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.

Journal for immunotherapy of cancer·2017
Same author

Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis.

Lupus·2017
Same author

Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6.

Alimentary pharmacology & therapeutics·2017
Same journal

The expanded cardiovascular risk prediction score as a cardiovascular mortality predictor in rheumatoid arthritis.

Clinical and experimental rheumatology·2026
Same journal

Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparison.

Clinical and experimental rheumatology·2026
Same journal

Clinical features and gastrointestinal bleeding risk factors in IgA vasculitis patients: a retrospective study in a large volume centre.

Clinical and experimental rheumatology·2026
Same journal

Reply to the comment on: The microbiota in axial spondyloarthritis: what have we learned from Mendelian randomisation studies?

Clinical and experimental rheumatology·2026
Same journal

Comprehensive evaluation of bone structural and microarchitectural changes in rheumatoid arthritis treated with baricitinib using HR-pQCT, imaging, and biomarker analyses.

Clinical and experimental rheumatology·2026
Same journal

Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy.

Clinical and experimental rheumatology·2026
See all related articles

Clinical practice guidelines (CPGs) offer evidence-based recommendations for healthcare decisions. However, many musculoskeletal disorder CPGs lack methodological transparency, hindering their optimal use and adoption by clinicians and patients.

Area of Science:

  • Rheumatology
  • Clinical Practice Guidelines
  • Evidence-Based Medicine

Background:

  • Clinical practice guidelines (CPGs) are essential tools for healthcare decision-making.
  • Rigorous CPGs require systematic development, evidence grading, and transparency.

Purpose of the Study:

  • To systematically review existing clinical practice guidelines for musculoskeletal disorders.
  • To assess the methodological quality and transparency of these guidelines.

Main Methods:

  • Systematic literature review and website search.
  • Identification and analysis of 276 CPGs for musculoskeletal disorders.
  • Evaluation of evidence grading and development processes.

Main Results:

Related Experiment Videos

  • 61 CPGs were analyzed from key sources like ACR and EULAR.
  • Many CPGs cited evidence but lacked details on systematic review and grading.
  • Significant overlap was observed in CPG development for specific diseases.

Conclusions:

  • CPGs can enhance care quality, but transparency in development is crucial.
  • Lack of explicit consensus processes and grading limits CPG interpretation and adoption.
  • Improved methodological rigor and transparency are needed for rheumatology CPGs.